| Update and rationale for ongoing acute myocardial infarction trials: combination therapy, facilitation, and myocardial preservation. | |
| | |
MedLine Citation:
|
PMID: 16777508 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Advancements in the treatment of myocardial infarction such as coronary care units, patient education, improved emergency response systems, and reperfusion therapy have reduced mortality. However, in an effort to further reduce the present rate by improving patency rates and microcirculatory perfusion, by better preserving myocardium, and/or treating shock more effectively, more research is under way to improve strategies now in place and to develop new, more effective ways to treat these patients. |
| | |
Authors:
|
Howard C Herrmann |
Related Documents
:
|
19591748 - Management of cardiogenic shock: focus on tissue perfusion. 14678138 - Optical mapping of transmural activation induced by electrical shocks in isolated left ... 17199948 - Surgical treatment of posttraumatic foreign bodies in the heart or great vessels. 17161048 - Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, unit... 2257788 - Effects of behavioural states on cardiac output in the healthy human fetus at 36-38 wee... 8794778 - Evaluation of body surface potential mapping changes after successful percutaneous tran... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: American heart journal Volume: 151 ISSN: 1097-6744 ISO Abbreviation: Am. Heart J. Publication Date: 2006 Jun |
Date Detail:
|
Created Date: 2006-06-16 Completed Date: 2006-06-21 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0370465 Medline TA: Am Heart J Country: United States |
Other Details:
|
Languages: eng Pagination: S30-9 Citation Subset: AIM; IM |
Affiliation:
|
Cardiac Catheterization Laboratories, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA. howard.herrmann@uphs.upenn.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary Clinical Trials as Topic* Hematologic Agents / therapeutic use Humans Myocardial Infarction / therapy* Myocardial Reperfusion* |
| Chemical | |
Reg. No./Substance:
|
0/Hematologic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Door-to-balloon delays with percutaneous coronary intervention in ST-elevation myocardial infarction...
Next Document: Insights into the pathophysiology of ST-elevation myocardial infarction.